Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRS [NASD]
Amyris, Inc.
Index- P/E- EPS (ttm)-1.72 Insider Own41.56% Shs Outstand267.73M Perf Week9.66%
Market Cap3.44B Forward P/E- EPS next Y-0.17 Insider Trans-3.94% Shs Float154.20M Perf Month-16.70%
Income-382.30M PEG- EPS next Q-0.13 Inst Own40.00% Short Float14.29% Perf Quarter-11.72%
Sales173.10M P/S19.90 EPS this Y29.60% Inst Trans16.20% Short Ratio4.62 Perf Half Y465.09%
Book/sh-1.20 P/B- EPS next Y-100.00% ROA- Target Price- Perf Year265.74%
Cash/sh0.52 P/C23.96 EPS next 5Y30.00% ROE- 52W Range1.88 - 23.42 Perf YTD103.16%
Dividend- P/FCF- EPS past 5Y40.80% ROI-269.30% 52W High-44.92% Beta1.18
Dividend %- Quick Ratio1.40 Sales past 5Y38.40% Gross Margin49.30% 52W Low588.00% ATR1.12
Employees595 Current Ratio1.70 Sales Q/Q507.90% Oper. Margin- RSI (14)44.65 Volatility8.84% 8.21%
OptionableYes Debt/Eq- EPS Q/Q-120.80% Profit Margin- Rel Volume0.47 Prev Close12.55
ShortableYes LT Debt/Eq- EarningsMay 06 BMO Payout- Avg Volume4.77M Price12.90
Recom1.60 SMA20-4.64% SMA50-21.84% SMA20051.80% Volume1,488,299 Change2.83%
Mar-03-21Reiterated H.C. Wainwright Buy $11 → $35
Feb-26-21Initiated ROTH Capital Buy $20
Jan-06-21Upgrade Cowen Market Perform → Outperform $9
Nov-25-20Initiated Jefferies Buy $3.35
Nov-25-20Initiated Cowen Market Perform $5
Dec-12-19Initiated Oppenheimer Outperform $8
Nov-14-18Reiterated B. Riley FBR Buy $10 → $8
Jan-25-18Initiated B. Riley FBR, Inc. Buy $8
May-28-14Resumed Stifel Hold
Feb-10-12Downgrade Deutsche Bank Buy → Hold $20 → $9
Nov-02-11Downgrade Robert W. Baird Outperform → Neutral $25 → $16
Jan-28-11Downgrade Stifel Nicolaus Buy → Hold
Nov-08-10Initiated Stifel Nicolaus Buy $22
May-18-21 08:00AM  
May-17-21 05:15PM  
May-11-21 03:56PM  
08:00AM  
May-07-21 01:01AM  
May-06-21 09:25AM  
08:00AM  
May-05-21 08:00AM  
07:07AM  
May-03-21 03:36PM  
03:23PM  
Apr-30-21 05:50PM  
Apr-29-21 05:06PM  
Apr-26-21 08:00AM  
Apr-21-21 08:00AM  
Apr-15-21 08:00AM  
Apr-14-21 08:00AM  
Apr-09-21 06:00AM  
Apr-07-21 05:45PM  
08:00AM  
Apr-05-21 04:05PM  
Apr-01-21 08:00AM  
Mar-31-21 08:00AM  
Mar-30-21 12:01PM  
Mar-29-21 04:58PM  
Mar-25-21 08:00AM  
Mar-16-21 08:00AM  
Mar-14-21 01:16PM  
Mar-12-21 10:50PM  
Mar-10-21 08:00AM  
Mar-09-21 08:00AM  
Mar-02-21 10:30PM  
08:47AM  
08:28AM  
07:36AM  
07:15AM  
Mar-01-21 10:12AM  
08:00AM  
Feb-26-21 10:50PM  
10:04AM  
Feb-25-21 08:00AM  
Feb-24-21 08:00AM  
Feb-22-21 08:00AM  
Feb-17-21 08:00AM  
Feb-10-21 08:00AM  
Feb-03-21 08:00AM  
Feb-02-21 08:00AM  
Jan-22-21 10:50PM  
08:00AM  
Jan-15-21 08:00AM  
Jan-11-21 08:00AM  
Jan-04-21 08:00AM  
Dec-28-20 08:00AM  
Dec-24-20 08:52AM  
Dec-21-20 09:30AM  
08:44AM  
08:00AM  
Dec-16-20 08:00AM  
Dec-11-20 10:34AM  
Dec-08-20 09:00AM  
Dec-03-20 08:00AM  
Nov-30-20 08:00AM  
Nov-23-20 08:00AM  
Nov-18-20 10:23AM  
Nov-05-20 08:00AM  
Oct-30-20 08:00AM  
Oct-26-20 11:00AM  
Oct-23-20 07:06PM  
08:00AM  
Oct-22-20 08:00AM  
Oct-20-20 09:30AM  
Oct-09-20 09:00AM  
Oct-08-20 09:00AM  
Oct-07-20 09:22AM  
Oct-01-20 08:30AM  
Sep-22-20 07:00PM  
Sep-21-20 08:30AM  
Sep-15-20 08:30AM  
Sep-14-20 07:00AM  
Sep-11-20 04:22PM  
03:25PM  
05:00AM  
Sep-10-20 03:41PM  
Sep-08-20 08:30AM  
Sep-04-20 08:50AM  
Sep-01-20 03:30PM  
08:30AM  
08:30AM  
Aug-20-20 08:31AM  
Aug-14-20 08:30AM  
Aug-06-20 08:30AM  
Jul-29-20 05:01PM  
12:25PM  
Jul-28-20 09:07PM  
Jul-27-20 12:41PM  
08:30AM  
Jul-23-20 08:30AM  
Jul-20-20 01:29PM  
01:20PM  
09:53AM  
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kung FrankDirectorApr 14Option Exercise4.761,212,7875,772,8666,796,205Apr 15 07:58 PM
Kung FrankDirectorApr 13Option Exercise4.261,943,6598,279,9878,463,618Apr 15 07:58 PM
Kung FrankDirectorApr 13Sale14.964,678,36370,000,006711,258Apr 15 07:58 PM
DOERR L JOHNDirectorDec 11Option Exercise2.875,000,00014,350,00070,156,794Dec 15 07:18 PM
Kung FrankDirectorJun 05Buy3.003,689,22511,067,6756,284,876Jun 09 09:06 PM